These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18389103)

  • 1. Molecule of the month. Elesclomol and obatoclax mesylate.
    Drug News Perspect; 2008 Mar; 21(2):123-4. PubMed ID: 18389103
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS
    J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
    [No Abstract]   [Full Text] [Related]  

  • 3. Unconventional therapies and cancer.
    Bégin M; Kaegi E
    CMAJ; 1999 Sep; 161(6):686-7. PubMed ID: 10513271
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitochondrial electron transport is the cellular target of the oncology drug elesclomol.
    Blackman RK; Cheung-Ong K; Gebbia M; Proia DA; He S; Kepros J; Jonneaux A; Marchetti P; Kluza J; Rao PE; Wada Y; Giaever G; Nislow C
    PLoS One; 2012; 7(1):e29798. PubMed ID: 22253786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, crystallographic characterization and electrochemical property of a copper(II) complex of the anticancer agent elesclomol.
    Vo NH; Xia Z; Hanko J; Yun T; Bloom S; Shen J; Koya K; Sun L; Chen S
    J Inorg Biochem; 2014 Jan; 130():69-73. PubMed ID: 24176921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hepatoma--controlled therapeutic trials. South African primary liver cancer research group. Initial report.
    S Afr Med J; 1967 Mar; 41(12):309-14. PubMed ID: 4290232
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
    Massenti S; Perri G
    Minerva Radiol; 1967 Apr; 12(4):140-4. PubMed ID: 5613803
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent acquisitions in cancer chemotherapy].
    Amiel JL; Bernard J; Bessis M; Dreyfus B; Najean Y; Seligmann M; Péquignot H
    Presse Med (1893); 1966 Jun; 74(32):1683-6. PubMed ID: 5935822
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with a methylhydrazine derivative (Natulan)].
    Hertz H; Hansen MM; Videbaek AA
    Ugeskr Laeger; 1966 Mar; 128(11):316-24. PubMed ID: 5331015
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells.
    Zheng LW; Wu LL; Zhao BX; Dong WL; Miao JY
    Bioorg Med Chem; 2009 Mar; 17(5):1957-62. PubMed ID: 19217789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemotherapy of malignant melanoma.
    Falkson G; van Dyk JJ
    S Afr Med J; 1968 Feb; 42(5):89-90. PubMed ID: 5647173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic treatment of melanoma?].
    Storck H
    Hautarzt; 1971 Oct; 22(10):456. PubMed ID: 5122289
    [No Abstract]   [Full Text] [Related]  

  • 15. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antineoplastic chemotherapy in 1980. Current status and prospects].
    Brun B; Rochant H
    Rev Prat; 1980 Jan; 30(5):209-18. PubMed ID: 6990462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].
    Kummer H; Bucher U
    Schweiz Med Wochenschr; 1965 Sep; 95(37):1233-40. PubMed ID: 5863643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent cytostatic therapy in hemoblastosis and malignant tumors].
    Kühböck J; Mannheimer E
    Wien Klin Wochenschr; 1966 Jul; 78(26):487-8. PubMed ID: 5992456
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel therapeutics for melanoma.
    Seetharamu N; Ott PA; Pavlick AC
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):839-49. PubMed ID: 19496721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictors or statistics versus individual effects of chemotherapy].
    Zaloudík J
    Vnitr Lek; 2002 Nov; 48(11):1001-3. PubMed ID: 12577447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.